2017
DOI: 10.5339/qmj.2017.swacelso.4
|View full text |Cite
|
Sign up to set email alerts
|

The journey of pediatric ECMO

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) diagram. PRISMA diagram describes the search methodology and extraction of articles for review (11). ECMO = extracorporeal membrane oxygenation.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) diagram. PRISMA diagram describes the search methodology and extraction of articles for review (11). ECMO = extracorporeal membrane oxygenation.…”
Section: Methodsmentioning
confidence: 99%
“…Studies on ECMO in neonates and pediatric patients were not conducted until 1976 and 1996, respectively (11). The earliest studies that identified EN while on ECMO were conducted in 1998 by Piena et al (12) and Pettignano et al (13).…”
Section: Study Selectionmentioning
confidence: 99%
“…The cohort in Nagle et al [7], which included patients requiring ECMO for pulmonary and cardiac indication, demonstrated a survival rate to discharge of only 41.7% after 9.4 days of mechanical life support. Current ELSO guidelines estimate survival rates of 50-60% in pediatric cardiac populations, whereas survival rates for ECMO due to pediatric respiratory failure have been described as being as high as 74% [2,21]. Although Nagle et al [7] demonstrated a lower rate of survival, the data provide evidence for efficacy of bivalirudin in short-term ECMO courses and supports the need for further, well-controlled studies.…”
Section: Duration Of Therapymentioning
confidence: 95%
“…In patients with cardiovascular disorders, including congenital heart disease in pediatrics, MCS is often utilized when conventional therapy fails. Extracorporeal membrane oxygenation (ECMO) is useful in patients who require short-term cardiac and/or respiratory support, as it provides complete cardiopulmonary bypass [1,2]. Meanwhile, ventricular assist devices (VADs) have served a variety of uses in patients with heart failure, including long-term use as bridging to transplantation or "destination therapy" in many adults.…”
Section: Introductionmentioning
confidence: 99%
“…Reported incidence of abnormal brain imaging in this population is between 28% and 52% (3). The overall survival for neonatal and pediatric patients supported by ECMO is around 60% (4, 5). For patients who develop brain injury, expected survival drops by nearly half (6).…”
mentioning
confidence: 99%